Updated:
Elaia Partners
Elaia Partners operates as a pan-European venture capital firm with a dual digital and deep tech mandate, investing from pre-seed through Series B.
Elaia Partners
Elaia Partners operates as a pan-European venture capital firm with a dual digital and deep tech mandate, investing from pre-seed through Series B. The firm builds its portfolio across enterprise software, artificial intelligence, biotechnology, and cybersecurity, with a geographic focus spanning France, the UK, and Israel. Confirmed positions include AI-driven drug discovery platform Aqemia, quantum computing startup Alice&Bob, and enterprise marketplace Mirakl. Its strategy emphasizes direct investments into technology-intensive startups, deploying from both its Digital Venture funds and a dedicated Deep Tech Seed fund. DTS3 closed at €134 million to back Europe's deep tech future, while Elaia DV5 achieved a first close of €120 million in June 2025. The firm participates heavily in seed rounds, recently leading a $16 million seed round for ETH robotics spinout Mimic and backing computational biology through Enodia Therapeutics' €20.7 million funding. Co-investors and portfolio companies span advanced manufacturing, agentic platforms, and next-generation AI infrastructure. Elaia's team page lists over 30 professionals with domain expertise ranging from material science to decarbonisation policy, suggesting a staffing model weighted toward technical due diligence. Recent operational events include the close of DV5's first tranche in June 2025, reinforcing a fundraising cadence that supports continuous deployment into Europe. The firm also publishes an annual sustainability report, signaling integration of ESG compliance into its investment process. What structurally separates Elaia is its full-stack approach: it funds startups from the earliest technical milestones and supports them through growth stages, rather than exiting after initial validation. This architecture creates asymmetric exposure to scientific risk but builds deeper technical conviction than stage-agnostic peers. The firm's absence of a disclosed flagship family backer or external parent entity positions it as an independent manager competing against larger institutional platforms for core deep tech allocations.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Middle East
Country
Israel
City
Tel Aviv
Corporate office
Tel Aviv, Israel
Sector focus
Frequently asked questions
How is Elaia Partners structured as an investment firm?
Elaia Partners operates as an independent venture capital manager, not a single-family office. It raises discrete fund vehicles — including its Digital Venture series and a dedicated Deep Tech Seed fund — to back technology startups from pre-seed through growth stages, without a disclosed parent entity or permanent capital base.
What investment stages does Elaia Partners target?
Elaia deploys from pre-seed to Series B across two fund families. The Digital Venture funds typically participate in seed through Series B rounds, while the Deep Tech Seed fund series concentrates on pre-seed and seed investments in scientific computing, biotech, and advanced engineering.
Which sectors does Elaia Partners explicitly focus on or avoid?
The firm's confirmed sector focuses include digital health, fintech, climate tech, insurtech, enterprise software, AI/ML, biotech, and cybersecurity — a mix of pure software and frontier science. There is no disclosed exclusion list, but its portfolio skews toward computationally intensive, IP-rich businesses rather than asset-light consumer platforms.
How does Elaia Partners source proprietary deal flow?
Elaia leverages a combination of scientific networks, academic spinout relationships, and internal domain experts to identify opportunities before competitive fundraising processes. Its team includes specialists in material science, energy systems, and biotech, who engage with research institutions and early-stage technical founders directly.
Does Elaia Partners participate in fund commitments or only direct deals?
Elaia concentrates on direct investments into startups rather than acting as a fund-of-funds. Portfolio activity shows lead and co-lead roles in seed and Series A rounds, with no publicly reported commitments to other venture capital funds.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: